Cardiac Rehabilitation and Additional Physical Training in Elderly Patients After Acute Coronary Syndrome

Sponsor
Lithuanian University of Health Sciences (Other)
Overall Status
Recruiting
CT.gov ID
NCT04768283
Collaborator
(none)
100
1
3
33.8
3

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate functional and physical capacity, health-related quality of life and associations with frailty in older patients after ischemic heart disease and interventional treatment with an individualized physical training program in the second phase of cardiac rehabilitation.

Condition or Disease Intervention/Treatment Phase
  • Other: Additional balance and resistance training - 1
  • Other: Additional balance and resistance training - 2
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Evaluation of Cardiac Rehabilitation Functional and Physical Capacity, Health-related Quality of Life and Associations With Frailty in Older Patients After Ischemic Heart Disease and Interventional Treatment
Actual Study Start Date :
Jan 6, 2020
Anticipated Primary Completion Date :
Oct 30, 2022
Anticipated Study Completion Date :
Oct 30, 2022

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control group

Cardiac rehabilitation physical training program included: respiratory muscle training (7 days/week, for 15 minutes) and aerobic exercises on cycle ergometers (6 days/week, for 10-30 minutes, 30-50% watts or 30-50% HRmax).

Experimental: Intervention group 1

Combinated physical training program: Respiratory exercises, aerobic training will be the same as in the control group. Additional exercises: balance training and strength exercises with weights, elastic resistance rubbers.

Other: Additional balance and resistance training - 1
Additional exercise program with balance and resistance training three times per week. The balance training included exercises to improve static as well as dynamic balance ability, for 15-20 minutes. The resistance training included exercises with weights (0,5, 1 or 2 kg), elastic resistance rubbers, intensity 30-50% 1-RM, 10 repetitions with 3 sets and 3 minute rest between sets.

Experimental: Intervention group 2

Combinated physical training program: Respiratory exercises, aerobic training will be the same as in the control group. Additional exercises: balance training with static and dynamic balance training device Biodex Balance System TM SD and strength exercises with HUR strength training machines.

Other: Additional balance and resistance training - 2
Additional exercise program with balance and resistance training three times per week. The balance training included exercises with static and dynamic balance training device Biodex Balance System TM SD, for 15-20 minutes. Exercises are performed with the following programs: Postural stability training, Limits of stability training, Weight shift training, Maze control training, Random control training, Percent weight-bearing training. The resistance training included exercises with HUR strength training machines, intensity 30-50% 1-RM, 10 repetitions with 3 sets and 3 minute rest between sets. Strength training was performed with the following exercises: Leg press, leg extension, leg abduction, leg adduction.

Outcome Measures

Primary Outcome Measures

  1. Frailty level by Edmonton frail scale score [baseline]

    Frailty measured by The Edmonton frail scale score - 0-3 - fit, 4-5 - vulnerable, 6-7 - mild frailty, 8-9 - moderate frailty,10-17 - severe frailty.

  2. Change from baseline functional capacity by six minutes walking test (6MWT) [baseline, 3 weeks]

    6MWT measured by meters

  3. Change from baseline cardiopulmonary exercise capacity by maximal load (maxWatt) [baseline, 3 weeks]

    Maximal load measured with spiroergometry by maximal watts

  4. Change from baseline cardiopulmonary exercise capacity by maximal oxygen consumption (peakVO2) [baseline, 3 weeks]

    PeakVO2 measured with spiroergometry by millilitres of oxygen per kilogram of body mass per minute

  5. Change from baseline quality of life by MacNew questionnaire [baseline, 3 weeks]

    The MacNew Heart Disease HRQL questionnaire consists of 27 items which fall into three domains (a 13-item physical limitations domain scale, a 14-item emotional function domain scale, and a 13-item social function domain scale). There are 5 items that inquire about symptoms: angina/chest pain, shortness of breath, fatigue, dizziness, and aching legs. The time frame for the MacNew is the previous two weeks.

Secondary Outcome Measures

  1. Change from baseline physical performance by Short Physical Performance Battery (SPPB) [baseline, 3 weeks]

    The short physical performance battery (SPPB) is a group of measures that combines the results of the gait speed, chair stand and balance tests.The scores range from 0 (worst performance) to 12 (best performance).

  2. Change from baseline muscular strength by one repetition maximum test (1RM) [baseline, 3 weeks]

    1RM test for leg extension measured by kilograms

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients after acute coronary syndrome and percutaneous coronary intervention or coronary bypass surgery;

  • Age 65 years and older;

  • 6-minute walk distance (6-MWD) ≥150 meters;

  • Left ventricular ejection fraction ≥ 40%;

  • Patient's agreement to participate in the study.

Exclusion Criteria:
  • combined coronary artery bypass grafting and valve surgery;

  • Cardiac devices;

  • Diseases in the musculoskeletal system or other organs complicating physical activity and exercise training;

  • Exercise-limiting comorbidities (primarily orthopedic and neurological conditions that would exclude individuals from participating in cardiac rehabilitation according to study protocol), cognitive or linguistic deficits.

Contacts and Locations

Locations

Site City State Country Postal Code
1 LUHS hospital Kaunas Clinics Rehabilitation hospital of Kulautuva Kulautuva Kaunas Lithuania

Sponsors and Collaborators

  • Lithuanian University of Health Sciences

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Aurelija Beigienė, Aurelija Beigienė, MD, Lithuanian University of Health Sciences
ClinicalTrials.gov Identifier:
NCT04768283
Other Study ID Numbers:
  • 2019-12-19 BE-2-107
First Posted:
Feb 24, 2021
Last Update Posted:
Mar 4, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Aurelija Beigienė, Aurelija Beigienė, MD, Lithuanian University of Health Sciences
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 4, 2021